Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cells - PubMed (original) (raw)
Affiliations
- PMID: 11531015
Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cells
J A McCubrey et al. Cancer Detect Prev. 2001.
Abstract
The PI3K/Akt and Raf/MEK/ERK signal transduction cascades are pivotal in transmitting signals from membrane receptors to downstream targets that regulate apoptosis, gene expression, and cell growth. The abilities of activated PI3K, Akt, Raf, and MEK proteins to abrogate the cytokine dependence of three different hematopoietic cell lines were determined. Activated PI3K or Akt expression by themselves did not efficiently annul cytokine dependence. Raf and MEK could abrogate the cytokine dependence of murine FDC-PI and human TF-1 cells; however, the frequency of transformation was dependent on the particular oncogene examined, as more factor-independent cells were isolated after infection with activated retroviruses encoding A-Raf or Raf-1 than were with MEK1 or B-Raf. Cytokine-independent deltaRaf-1-infected cells formed tumors on injection into immunocompromised mice, whereas cytokine-dependent cell lines did not, demonstrating the oncogenic effects of activation of the Raf/MEK/ERK pathway. Overexpression of the antiapoptotic Bcl-2 protein synergized with activation of the Raf/MEK/ERK cascade and increased the efficiency of transformation of FDC-PI and TF-1 cells. In contrast to the results observed with FDC-P1 and TF-I cells, the activated Raf genes did not relieve the cytokine dependence of murine FL5.12 cells. The abilities of the Raf and PI3K pathways to interact and annul the cytokine dependence of FL5.12 cells were determined. The combination of Raf and either PI3K or Akt expression relieved cytokine dependence of some FL5.12 cells, and the efficiency of transformation could be enhanced further by Bcl-2 or Bcl-XL overexpression. Thus, the antiapoptotic PI3K/Akt and Bcl-2/Bcl-XL proteins can interact with the growth-promoting Raf/MEK/ERK pathway and annul the cytokine dependence of certain hematopoietic cells.
Similar articles
- Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells.
Shelton JG, Steelman LS, Lee JT, Knapp SL, Blalock WL, Moye PW, Franklin RA, Pohnert SC, Mirza AM, McMahon M, McCubrey JA. Shelton JG, et al. Oncogene. 2003 Apr 24;22(16):2478-92. doi: 10.1038/sj.onc.1206321. Oncogene. 2003. PMID: 12717425 - Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M. McCubrey JA, et al. Adv Enzyme Regul. 2006;46:249-79. doi: 10.1016/j.advenzreg.2006.01.004. Epub 2006 Jul 18. Adv Enzyme Regul. 2006. PMID: 16854453 - Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation.
Shelton JG, Moye PW, Steelman LS, Blalock WL, Lee JT, Franklin RA, McMahon M, McCubrey JA. Shelton JG, et al. Leukemia. 2003 Sep;17(9):1765-82. doi: 10.1038/sj.leu.2403052. Leukemia. 2003. PMID: 12970777 - Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.
Chang F, Steelman LS, Lee JT, Shelton JG, Navolanic PM, Blalock WL, Franklin RA, McCubrey JA. Chang F, et al. Leukemia. 2003 Jul;17(7):1263-93. doi: 10.1038/sj.leu.2402945. Leukemia. 2003. PMID: 12835716 Review. - Tangled webs: evidence of cross-talk between c-Raf-1 and Akt.
Jun T, Gjoerup O, Roberts TM. Jun T, et al. Sci STKE. 1999 Dec 21;1999(13):PE1. doi: 10.1126/stke.1999.13.pe1. Sci STKE. 1999. PMID: 11865188 Review.
Cited by
- Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance.
McCubrey JA, Steelman LS, Franklin RA, Abrams SL, Chappell WH, Wong EW, Lehmann BD, Terrian DM, Basecke J, Stivala F, Libra M, Evangelisti C, Martelli AM. McCubrey JA, et al. Adv Enzyme Regul. 2007;47:64-103. doi: 10.1016/j.advenzreg.2006.12.013. Epub 2007 Mar 26. Adv Enzyme Regul. 2007. PMID: 17382374 Free PMC article. No abstract available. - Targeting prostate cancer based on signal transduction and cell cycle pathways.
Lee JT, Lehmann BD, Terrian DM, Chappell WH, Stivala F, Libra M, Martelli AM, Steelman LS, McCubrey JA. Lee JT, et al. Cell Cycle. 2008 Jun 15;7(12):1745-62. doi: 10.4161/cc.7.12.6166. Epub 2008 Jun 16. Cell Cycle. 2008. PMID: 18594202 Free PMC article. Review. - The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt.
Somanath PR, Vijai J, Kichina JV, Byzova T, Kandel ES. Somanath PR, et al. Oncogene. 2009 Jun 25;28(25):2365-9. doi: 10.1038/onc.2009.114. Epub 2009 May 4. Oncogene. 2009. PMID: 19421139 Free PMC article. - Protein phosphatase 1γ isoforms linked interactions in the brain.
Esteves SL, Korrodi-Gregório L, Cotrim CZ, van Kleeff PJ, Domingues SC, da Cruz e Silva OA, Fardilha M, da Cruz e Silva EF. Esteves SL, et al. J Mol Neurosci. 2013 May;50(1):179-97. doi: 10.1007/s12031-012-9902-6. Epub 2012 Oct 19. J Mol Neurosci. 2013. PMID: 23080069
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous